Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Walgreen

This article was originally published in The Tan Sheet

Executive Summary

U.S. leading pharmacy chain plans to add to online offerings to include consumer goods such as vitamins, OTCs drugs, cosmetics, school supplies, batteries and camera film with expansion of its Web site in the coming months. The company, which currently offers only Rx drugs on its site, also is working on a major expansion of its bricks-and-mortar locations with 450 new stores expected to open this fiscal year. According to Walgreen, the delayed opening of the Web site is attributed to distribution glitches; the company plans to use its existing facilities to handle distribution. Rival Phar Mor recently launched PharMore.com in conjunction with More.com (1see story, p. 17)

You may also be interested in...



PharMore.com Co-Branded Web Site Partners More.com With Retail Chain

More.com and discount drug chain Phar Mor are embarking upon a new model of "clicks-and-mortar" cooperation with the July 11 premiere of the co-branded PharMore.com Web site.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091445

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel